Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection
NCT03261791
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG:
Apatinib
Sponsor
Shanghai Zhongshan Hospital